Any stock, in context
AJANTPHARM · Healthcare
Ajanta Pharmaceuticals Ltd.
Observation · 15 Oct 2026
How these are readAjanta Pharmaceuticals closed at ₹3,359.4 on 15 Oct 2026, 7.9% above its 200-day average and 5.0% below its 50-day average: above the long line, below the short one. It sits 9.7% below its highest close of the past year, in the fourth fifth of its one-year range. Over three months it fell 0.9%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- vs 200-day
- +7.9%
- the long line
- vs 50-day
- −5.0%
- the short line
- From 52w high
- −9.7%
- ₹2,382.0₹3,796.0
- 3 months
- −0.8%
- sector median −2.7% · 69 of 146
Nifty Midcap 150 · Healthcare · EQ series · median traded value ₹30 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- +1.83%
- 1W
- –
- 1M
- −4.30%
- 3M
- −0.85%
- YTD
- –
- 1Y
- +42.27%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.